For small and emerging biotech companies, clinical trial design can determine success or failure. Every study must balance scientific rigor, regulatory expectations, and financial constraints while delivering meaningful results.
In this conference poster, Toby Batten, Senior Manager Statistics, highlights the critical role of statisticians in shaping effective, cost-efficient studies that maximize the probability of clinical trial success.
By aligning stakeholder priorities, including investors, clinical teams, regulators, and patients, biotechs can design smarter trials that deliver high-quality data without exceeding budgets. Leveraging expertise from biostatistics consultants and specialized biometrics clinical research organizations (CROs) enables faster, more confident decision-making across the drug development lifecycle.
Key Focus Areas
- Strategic clinical trial design
- Balancing cost, logistics, and statistical rigor
- Enhancing outcomes through biostatistics and biometrics
- Supporting small biotech growth and sustainability
Click on the poster below to discover how you can optimize your study design and improve your chances of success in an increasingly competitive biotech landscape.
